Leerink Partnrs Predicts Enhabit’s Q4 Earnings (NYSE:EHAB)

Enhabit, Inc. (NYSE:EHAB) – Equities research analysts at Leerink Partnrs upped their Q4 2025 earnings estimates for Enhabit in a report released on Monday, November 18th. Leerink Partnrs analyst W. Mayo now expects that the company will post earnings per share of $0.08 for the quarter, up from their previous estimate of $0.05. The consensus estimate for Enhabit’s current full-year earnings is $0.25 per share.

Enhabit (NYSE:EHAB) last issued its quarterly earnings results on Wednesday, November 6th. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.01). The company had revenue of $253.60 million during the quarter, compared to the consensus estimate of $261.69 million. Enhabit had a positive return on equity of 1.67% and a negative net margin of 11.24%. During the same quarter last year, the firm posted $0.03 EPS.

Separately, Leerink Partners reaffirmed a “market perform” rating and issued a $8.00 price objective (down previously from $8.50) on shares of Enhabit in a report on Tuesday. One analyst has rated the stock with a sell rating and six have given a hold rating to the company. According to MarketBeat.com, Enhabit currently has an average rating of “Hold” and a consensus target price of $9.25.

Enhabit Stock Up 1.8 %

Shares of NYSE:EHAB opened at $7.27 on Wednesday. The firm has a market cap of $365.31 million, a PE ratio of -3.13 and a beta of 1.84. The company has a fifty day simple moving average of $7.54 and a 200 day simple moving average of $8.43. The company has a current ratio of 1.46, a quick ratio of 1.46 and a debt-to-equity ratio of 0.85. Enhabit has a 12-month low of $6.85 and a 12-month high of $11.74.

Institutional Investors Weigh In On Enhabit

Several hedge funds and other institutional investors have recently bought and sold shares of EHAB. FMR LLC raised its position in Enhabit by 138.4% in the third quarter. FMR LLC now owns 3,388 shares of the company’s stock worth $27,000 after acquiring an additional 1,967 shares in the last quarter. Gladius Capital Management LP bought a new stake in Enhabit in the second quarter worth about $31,000. Quarry LP raised its position in Enhabit by 242.2% in the second quarter. Quarry LP now owns 3,703 shares of the company’s stock worth $33,000 after acquiring an additional 2,621 shares in the last quarter. Allspring Global Investments Holdings LLC bought a new stake in Enhabit in the first quarter worth about $44,000. Finally, Stoneridge Investment Partners LLC bought a new stake in Enhabit in the third quarter worth about $81,000.

Insider Activity at Enhabit

In other Enhabit news, Director Jeffrey Bolton purchased 5,000 shares of the company’s stock in a transaction on Thursday, August 22nd. The shares were purchased at an average cost of $8.01 per share, for a total transaction of $40,050.00. Following the completion of the transaction, the director now owns 78,877 shares in the company, valued at $631,804.77. The trade was a 6.77 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.90% of the company’s stock.

About Enhabit

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.